Germing U - Search Results

1

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.

Platzbecker U, Germing U, Götze KS, Kiewe P, Mayer K, Chromik J, Radsak M, Wolff T, Zhang X, Laadem A, Sherman ML, Attie KM, Giagounidis A. Platzbecker U, et al. Among authors: germing u. Lancet Oncol. 2017 Oct;18(10):1338-1347. doi: 10.1016/S1470-2045(17)30615-0. Epub 2017 Sep 1. Lancet Oncol. 2017. PMID: 28870615 Clinical Trial.

2

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Aul C, Gattermann N, Germing U, Runde V, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1992 Aug 14;117(33):1223-31. doi: 10.1055/s-2008-1062434. Dtsch Med Wochenschr. 1992. PMID: 1499520 German.

3

Risk assessment in primary myelodysplastic syndromes: validation of the Düsseldorf score.

Aul C, Gattermann N, Germing U, Runde V, Heyll A, Schneider W. Aul C, et al. Among authors: germing u. Leukemia. 1994 Nov;8(11):1906-13. Leukemia. 1994. PMID: 7967735

4

[The prognostic significance of serum thymidine kinase in the myelodysplastic syndrome].

Aul C, Germing U, Gattermann N, Söhngen D, Heyll A. Aul C, et al. Among authors: germing u. Dtsch Med Wochenschr. 1996 Sep 13;121(37):1113-8. doi: 10.1055/s-2008-1043114. Dtsch Med Wochenschr. 1996. PMID: 8925725 German.

5

[Myelodysplastic syndromes].

Aul C, Germing U. Aul C, et al. Among authors: germing u. Internist (Berl). 1998 Nov;39(11):1168-80. Internist (Berl). 1998. PMID: 9859051 Review. German. No abstract available.

6

Pseudomonas aeruginosa orbital phlegmon in a patient treated for myelodysplastic syndrome with concomitant Sjögren's syndrome.

Giagounidis AA, Giagounidis AS, Germing U, Koch JA, Aul C. Giagounidis AA, et al. Among authors: germing u. Eur J Med Res. 1999 Jan 26;4(1):27-30. Eur J Med Res. 1999. PMID: 9892572

7

[Role of aggressive treatment strategies for myelodysplastic syndromes].

Aul C, Germing U, Minning H, Kobbe G, Gattermann N, Südhoff T, Meckenstock G, Söhngen D, Heyll A. Aul C, et al. Among authors: germing u. Praxis (Bern 1994). 1999 Mar 4;88(10):431-8. Praxis (Bern 1994). 1999. PMID: 10199215 Review. German.

8

[Clinical course, morphology and prognosis of chronic myelomonocytic leukemia].

Germing U, Strupp C, Meckenstock G, Giagounidis A, Minning H, Aul C. Germing U, et al. Med Klin (Munich). 1999 Sep 15;94(9):467-72. doi: 10.1007/BF03044937. Med Klin (Munich). 1999. PMID: 10544608 German.

9

Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics.

Aul C, Giagounidis A, Germing U. Aul C, et al. Among authors: germing u. Int J Hematol. 2001 Jun;73(4):405-410. doi: 10.1007/BF02994001. Int J Hematol. 2001. PMID: 11503953 Review.

10

Favourable response to antithymocyte or antilymphocyte globulin in low-risk myelodysplastic syndrome patients with a 'non-clonal' pattern of X-chromosome inactivation in bone marrow cells.

Aivado M, Rong A, Stadler M, Germing U, Giagounidis A, Strupp C, Novotny J, Josten KM, Kobbe G, Hildebrandt B, Gattermann N, Aul C, Haas R, Ganser A. Aivado M, et al. Among authors: germing u. Eur J Haematol. 2002 Apr;68(4):210-6. doi: 10.1034/j.1600-0609.2002.01625.x. Eur J Haematol. 2002. PMID: 12071936 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

426 results

Search Page